+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Intelligence in Genomics Market Outlook 2026-2034: Market Size, Share, Trends and Competitive Analysis

  • PDF Icon

    Report

  • 160 Pages
  • November 2026
  • Region: Global
  • OG Analysis
  • ID: 6229629
UP TO OFF until Jan 01st 2027
The Artificial Intelligence in Genomics Market is estimated at USD 1.58 billion in 2026 and is projected to reach USD 20.90 billion by 2034, growing at a CAGR of 38.1% during 2026-2034.

Market Overview

The Artificial Intelligence in Genomics Market covers artificial intelligence tools and platforms applied to genomic data interpretation, molecular insight generation, biomarker discovery, and precision medicine development. Its value chain includes sequencing providers, cloud infrastructure companies, bioinformatics developers, pharmaceutical companies, research institutions, hospitals, and data analytics platforms. Commercial demand is linked to interpreting genomic information. The technical direction includes multimodal variant analysis and data-efficient models, while adoption is constrained by population bias and complex data governance. Buyers compare analytical validity, traceability and appropriate interpretation, making application suitability more important than a broad specification alone. Regional analysis considers North American genomics platforms; European research networks; Asian molecular laboratories. The report examines these relationships across demand, supply and competitive positioning. It connects customer requirements with implementation barriers and the conditions needed for sustainable commercial participation. The analysis helps readers distinguish established operating needs from emerging opportunities and evaluate how purchasing decisions differ across customers, channels and local market conditions.

Key Takeaways

  • Demand drivers: Demand is linked to interpreting genomic information. Purchasing depends on analytical validity, traceability and appropriate interpretation, with different users balancing technical value and implementation effort. This makes the relationship between end-use activity and actual supplier orders important to understanding commercial prospects.
  • Technology direction: Multimodal variant analysis and data-efficient models provides a focus for development. Practical adoption still depends on analytical validity, traceability and appropriate interpretation. Buyers need a clear match between the proposed improvement and their operating requirements, rather than relying on technical novelty as proof of value.
  • Key market distinctions: Product and service differentiation centers on analytical validity, traceability and appropriate interpretation. Buyers serving interpreting genomic information may have different qualification and delivery needs, so a broad market definition should not be treated as evidence that all offerings or customer applications are commercially interchangeable.
  • Adoption challenges: Population bias and complex data governance can limit deployment or lengthen purchasing decisions. Their importance varies with the use case and customer resources. Commercial planning should account for qualification, implementation and support requirements before assuming that demand will translate directly into sustained adoption.
  • Competitive positioning: Illumina, Tempus, NVIDIA are among the participants included for comparison. Competitive assessment focuses on analytical validity, traceability and appropriate interpretation. The relevant distinction is each participant’s role and offering, since suppliers, technology partners and service providers do not necessarily compete across the same activities.
  • Geographic dynamics: The regional picture links North American genomics platforms; European research networks; Asian molecular laboratories. These settings differ in customer priorities, supply capabilities and purchasing structures. Geographic opportunity therefore depends on local adoption conditions and channel access, without assuming that a single regional pattern describes the entire global market.
  • Buyer economics: Subscription pricing is only part of implementation economics. Buyers also assess migration effort, staff training, administration and operational disruption, making a clear deployment plan and demonstrable workflow improvement important to renewals and broader enterprise adoption.
  • Supply and delivery: Software partners, implementation specialists and customer-success teams shape delivery quality. Buyers need clarity on data ownership, support responsibilities and interoperability, particularly where a platform becomes embedded in decisions that span several systems or business functions.
  • Routes to market: Enterprise sales, channel partners and implementation-led customer relationships shape commercial access for Artificial Intelligence in Genomics. Requirements involving data protection, access controls, auditability and responsible automation also affect participation. Suppliers need to understand customer approval processes and channel responsibilities when selecting an expansion strategy or developing a differentiated offering.
  • Strategic opportunities: Domain-specific workflows and interoperable integrations provide a practical path to differentiation. Providers can address underserved users by reducing implementation friction and making outcomes easier to assess, rather than relying on feature expansion without a clear operating use case.

Artificial Intelligence in Genomics Market Analytics

The report applies Porter’s Five Forces, value-chain mapping and scenario analysis to the Artificial Intelligence in Genomics Market. Supply and demand are examined alongside customer requirements, substitute offerings and adjacent market influences. Analysis of interpreting genomic information and multimodal variant analysis and data-efficient models helps explain the conditions supporting adoption. Pricing and procurement dynamics are considered in relation to analytical validity, traceability and appropriate interpretation. Service delivery, access conditions and the role of implementation partners are considered where relevant. The framework connects data protection, access controls, auditability and responsible automation with market opportunities and risks, helping readers evaluate operating assumptions and the potential consequences of changing industry conditions.

Artificial Intelligence in Genomics Market Competitive Intelligence

The Artificial Intelligence in Genomics Market is assessed through participant capabilities, customer relationships and the practical requirements of interpreting genomic information. Companies covered include Illumina, Tempus, NVIDIA, alongside the complete list below. The comparison considers analytical validity, traceability and appropriate interpretation, portfolio fit and the ability to respond to population bias and complex data governance. Strategic opportunities around multimodal variant analysis and data-efficient models are examined in the context of application needs and delivery capabilities. The analysis distinguishes manufacturers, technology suppliers and service participants where relevant, helping readers assess complementary partnerships as well as direct competition. The profiles help readers distinguish direct competitors from complementary partners and compare strategic fit across the value chain.

Companies Mentioned

  • Illumina
  • Tempus
  • NVIDIA
  • Google
  • Microsoft
  • IBM
  • DNAnexus
  • Fabric Genomics
  • Deep Genomics
  • BenevolentAI
  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • SOPHiA GENETICS
  • BioMarin
  • 23andMe
  • Labcorp
  • Guardant Health
  • Oxford Nanopore
  • BGI Genomics

Countries Covered

North America - Artificial Intelligence in Genomics Market data and outlook to 2034

  • United States
  • Canada
  • Mexico

Europe - Artificial Intelligence in Genomics Market data and outlook to 2034

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • BeNeLux
  • Russia
  • Sweden

Asia-Pacific - Artificial Intelligence in Genomics Market data and outlook to 2034

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam

Middle East and Africa - Artificial Intelligence in Genomics Market data and outlook to 2034

  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt

South and Central America - Artificial Intelligence in Genomics Market data and outlook to 2034

  • Brazil
  • Argentina
  • Chile
  • Peru
Additional country data and analysis can be included on demand.

Research Methodology

This study combines primary inputs from industry experts across the Artificial Intelligence in Genomics value chain with secondary data from associations, government publications, trade databases and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation and scenario planning, are applied to support market sizing and forecasting. Market definitions and the roles of different participants are considered when comparing inputs and interpreting the outlook.

Key Questions Addressed

  • What is the current and forecast outlook for the Artificial Intelligence in Genomics Market across the covered geographies?
  • How do interpreting genomic information influence customer needs and purchasing decisions?
  • What opportunities and barriers are associated with multimodal variant analysis and data-efficient models?
  • How do customers assess analytical validity, traceability and appropriate interpretation?
  • How are companies responding to population bias and complex data governance?
  • Which applications, customer groups and partnership models offer relevant routes to market?
  • How do policy, supply conditions and competitive capabilities affect strategic choices?

Your Key Takeaways from the Artificial Intelligence in Genomics Market Report

  • Artificial Intelligence in Genomics market size and growth outlook across the covered regions and countries
  • Market-specific trends, demand drivers, adoption challenges and opportunities
  • Analysis of the market definition, customer requirements and application opportunities
  • Commercial implications of multimodal variant analysis and data-efficient models
  • Competitive positioning and capabilities of the companies mentioned
  • Purchasing considerations involving analytical validity, traceability and appropriate interpretation
  • Geographic and supply-chain factors associated with North American genomics platforms; European research networks; Asian molecular laboratories
  • Porter’s Five Forces, value-chain analysis and scenario-based strategic assessment
  • Relevant market developments and their implications for business planning

This product will be delivered within 1-3 business days.

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Global Artificial Intelligence in Genomics Market Summary, 2026
2.1 Artificial Intelligence in Genomics Industry Overview
2.1.1 Global Artificial Intelligence in Genomics Market Revenues (In US$ billion)
2.2 Artificial Intelligence in Genomics Market Scope
2.3 Research Methodology
3. Artificial Intelligence in Genomics Market Insights, 2025-2035
3.1 Artificial Intelligence in Genomics Market Drivers
3.2 Artificial Intelligence in Genomics Market Restraints
3.3 Artificial Intelligence in Genomics Market Opportunities
3.4 Artificial Intelligence in Genomics Market Challenges
3.5 Tariff Impact on Global Artificial Intelligence in Genomics Supply Chain Patterns
4. Artificial Intelligence in Genomics Market Analytics
4.1 Artificial Intelligence in Genomics Market Size and Share, Key Product, 2026 Vs 2035
4.2 Artificial Intelligence in Genomics Market Size and Share, Dominant Application, 2026 Vs 2035
4.3 Artificial Intelligence in Genomics Market Size and Share, Leading Sales Channel, 2026 Vs 2035
4.4 Artificial Intelligence in Genomics Market Size and Share, High Growth Countries, 2026 Vs 2035
4.5 Five Forces Analysis for Global Artificial Intelligence in Genomics Market
4.5.1 Artificial Intelligence in Genomics Industry Attractiveness Index, 2026
4.5.2 Artificial Intelligence in Genomics Supplier Intelligence
4.5.3 Artificial Intelligence in Genomics Buyer Intelligence
4.5.4 Artificial Intelligence in Genomics Competition Intelligence
4.5.5 Artificial Intelligence in Genomics Product Alternatives and Substitutes Intelligence
4.5.6 Artificial Intelligence in Genomics Market Entry Intelligence
5. Global Artificial Intelligence in Genomics Market Statistics - Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2035
5.1 World Artificial Intelligence in Genomics Market Size, Potential and Growth Outlook, 2025-2035
5.1 Global Artificial Intelligence in Genomics Sales Outlook and CAGR Growth By Product, 2025-2035
5.2 Global Artificial Intelligence in Genomics Sales Outlook and CAGR Growth By Application, 2025-2035
5.3 Global Artificial Intelligence in Genomics Sales Outlook and CAGR Growth By Sales Channel, 2025-2035
5.4 Global Artificial Intelligence in Genomics Market Sales Outlook and Growth by Region, 2025-2035
6. Asia-Pacific Artificial Intelligence in Genomics Industry Statistics - Market Size, Share, Competition and Outlook
6.1 Asia-Pacific Artificial Intelligence in Genomics Market Insights, 2026
6.2 Asia-Pacific Artificial Intelligence in Genomics Market Revenue Forecast By Product, 2025-2035
6.3 Asia-Pacific Artificial Intelligence in Genomics Market Revenue Forecast By Application, 2025-2035
6.4 Asia-Pacific Artificial Intelligence in Genomics Market Revenue Forecast By Sales Channel, 2025-2035
6.5 Asia-Pacific Artificial Intelligence in Genomics Market Revenue Forecast by Country, 2025-2035
6.5.1 China Artificial Intelligence in Genomics Market Size, Opportunities, Growth 2025-2035
6.5.2 India Artificial Intelligence in Genomics Market Size, Opportunities, Growth 2025-2035
6.5.3 Japan Artificial Intelligence in Genomics Market Size, Opportunities, Growth 2025-2035
6.5.4 Australia Artificial Intelligence in Genomics Market Size, Opportunities, Growth 2025-2035
7. Europe Artificial Intelligence in Genomics Market Data, Penetration, and Business Prospects to 2035
7.1 Europe Artificial Intelligence in Genomics Market Key Findings, 2026
7.2 Europe Artificial Intelligence in Genomics Market Size and Percentage Breakdown By Product, 2025-2035
7.3 Europe Artificial Intelligence in Genomics Market Size and Percentage Breakdown By Application, 2025-2035
7.4 Europe Artificial Intelligence in Genomics Market Size and Percentage Breakdown By Sales Channel, 2025-2035
7.5 Europe Artificial Intelligence in Genomics Market Size and Percentage Breakdown by Country, 2025-2035
7.5.1 Germany Artificial Intelligence in Genomics Market Size, Trends, Growth Outlook to 2035
7.5.2 United Kingdom Artificial Intelligence in Genomics Market Size, Trends, Growth Outlook to 2035
7.5.2 France Artificial Intelligence in Genomics Market Size, Trends, Growth Outlook to 2035
7.5.2 Italy Artificial Intelligence in Genomics Market Size, Trends, Growth Outlook to 2035
7.5.2 Spain Artificial Intelligence in Genomics Market Size, Trends, Growth Outlook to 2035
8. North America Artificial Intelligence in Genomics Market Size, Growth Trends, and Future Prospects to 2035
8.1 North America Snapshot, 2026
8.2 North America Artificial Intelligence in Genomics Market Analysis and Outlook By Product, 2025-2035
8.3 North America Artificial Intelligence in Genomics Market Analysis and Outlook By Application, 2025-2035
8.4 North America Artificial Intelligence in Genomics Market Analysis and Outlook By Sales Channel, 2025-2035
8.5 North America Artificial Intelligence in Genomics Market Analysis and Outlook by Country, 2025-2035
8.5.1 United States Artificial Intelligence in Genomics Market Size, Share, Growth Trends and Forecast, 2025-2035
8.5.1 Canada Artificial Intelligence in Genomics Market Size, Share, Growth Trends and Forecast, 2025-2035
8.5.1 Mexico Artificial Intelligence in Genomics Market Size, Share, Growth Trends and Forecast, 2025-2035
9. South and Central America Artificial Intelligence in Genomics Market Drivers, Challenges, and Future Prospects
9.1 Latin America Artificial Intelligence in Genomics Market Data, 2026
9.2 Latin America Artificial Intelligence in Genomics Market Future By Product, 2025-2035
9.3 Latin America Artificial Intelligence in Genomics Market Future By Application, 2025-2035
9.4 Latin America Artificial Intelligence in Genomics Market Future By Sales Channel, 2025-2035
9.5 Latin America Artificial Intelligence in Genomics Market Future by Country, 2025-2035
9.5.1 Brazil Artificial Intelligence in Genomics Market Size, Share and Opportunities to 2035
9.5.2 Argentina Artificial Intelligence in Genomics Market Size, Share and Opportunities to 2035
10. Middle East Africa Artificial Intelligence in Genomics Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2026
10.2 Middle East Africa Artificial Intelligence in Genomics Market Statistics By Product, 2025-2035
10.3 Middle East Africa Artificial Intelligence in Genomics Market Statistics By Application, 2025-2035
10.4 Middle East Africa Artificial Intelligence in Genomics Market Statistics By Sales Channel, 2025-2035
10.5 Middle East Africa Artificial Intelligence in Genomics Market Statistics by Country, 2025-2035
10.5.1 Middle East Artificial Intelligence in Genomics Market Value, Trends, Growth Forecasts to 2035
10.5.2 Africa Artificial Intelligence in Genomics Market Value, Trends, Growth Forecasts to 2035
11. Artificial Intelligence in Genomics Market Structure and Competitive Landscape
11.1 Key Companies in Artificial Intelligence in Genomics Industry
11.2 Artificial Intelligence in Genomics Business Overview
11.3 Artificial Intelligence in Genomics Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis
12. Appendix
12.1 Global Artificial Intelligence in Genomics Market Volume (Tons)
12.1 Global Artificial Intelligence in Genomics Trade and Price Analysis
12.2 Artificial Intelligence in Genomics Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Artificial Intelligence in Genomics Industry Report Sources and Methodology

Companies Mentioned

  • Illumina
  • Tempus
  • NVIDIA
  • Google
  • Microsoft
  • IBM
  • DNAnexus
  • Fabric Genomics
  • Deep Genomics
  • BenevolentAI
  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • SOPHiA GENETICS
  • BioMarin
  • 23andMe
  • Labcorp
  • Guardant Health
  • Oxford Nanopore
  • BGI Genomics

Table Information